Prevalence of Sleep Apnea Syndrome in Patients With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

April 11, 2019

Study Completion Date

April 11, 2019

Conditions
Diabetes Mellitus, Type 1
Interventions
OTHER

standard polysomnography

All participants were admitted in sleep laboratory and screened for one night of 8 hours employing standard polysomnography (Brainnet System - Medatec) parameters : electroencephalogram, electro-oculogram, electromyogram \[chin\], continuous nasal airflow body position, thoracic and abdominal strain gauges, haemoglobin oxygen saturation (SaO2) with an oximeter (Medatec) attached to finger. Blood pressure was measured in the evening during the physical examines, and then the CGMS recording startedpressure was measured in the evening during the physical examines, and then the CGMS recording started

Trial Locations (1)

80000

Chu Amiens Picardie, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03506022 - Prevalence of Sleep Apnea Syndrome in Patients With Type 1 Diabetes | Biotech Hunter | Biotech Hunter